Argentina's Cannabis Regulatory Agency, ARICCAME, recently granted the first six licenses for the production and marketing of medical cannabis. This decision constitutes an important step towards achieving the objectives set out in Law 27.669, which establishes the regulatory framework for the national medical cannabis and hemp industry.
Approved businesses
The six companies that received these pioneering licenses are Agrogenetica Riojana and Biofábrica Misiones from La Rioja, Inkillay from Tucumán, Whale Leaf from Chubut, and Botannicans and Pampa Hemp from Buenos Aires. Francisco Echarren, president of ARICCAME, expressed his satisfaction, emphasizing that these licenses mark the beginning of a new era for the national industry, in accordance with the provisions of Law 27.669.
Argentina believes in the economic potential of the medical cannabis and industrial hemp industry. Official figures indicate the sector could generate up to 10,000 registered jobs over the next three years, with a domestic market estimated at $500 million. Experts are also excited about the possibility of additional exports of up to $1 billion. Pablo Fazio, president of the Argentine Cannabis Chamber, considers these developments a “historic triumph” and believes it is just the starting point for the Argentine cannabis industry.
Challenges and perspectives
As ARICCAME's new management takes office, a one-stop shop, designed for the presentation of productive projects, should be quickly operational. It will ensure speedy bidding for production licenses and open up opportunities for various players across the country. Rolando García, researcher, underlines at Sechat that effective public policies for the cannabis industry require dynamic regulation capable of meeting the diverse needs of all stakeholders.
In a global context where the legal cannabis industry is booming, Argentina has the potential to emerge as a leader in the sector. With more than 53 projects authorized in 17 provinces and the possibility of mobilizing up to $500 million per year on the domestic market, the country is at a turning point. The Argentine Cannabis Chamber (ArgenCann) forecasts $1 billion in exports and the creation of 10,000 jobs over the next four years, matching global growth forecasts for the legal cannabis industry.
Concerns over political changes
Recent political changes, including the election of new president Javier Milei, have raised concerns within the cannabis industry. The resignation of ARICCAME's president and directors, coupled with uncertainty regarding the continuity of the agency, has sparked apprehension among industry players. Pablo Fazio, president of ArgenCann, highlights the importance of continuity of public policies to ensure the growth and sustainability of the industry.
Valeria Salech, president of the NGO Mama Cultiva Argentina, speaks on ElPlanteo the importance of dialogue and hopes for an accessible, diverse and plural cannabis market that respects individual freedom. Dr. César Dip, a specialist in pain medicine and cannabis, is concerned about the potential privatization of the public health system and its impact on medical cannabis users.
Despite the challenges, Pablo Fazio calls for calm and the reconstruction of agendas, foreseeing the need for a more orderly and open market, especially in terms of foreign trade. Concerns persist about potential risks, including increased repression and persecution of cannabis users and producers. Industry lawyer Piero Liebman warns of regulatory uncertainty and its potential impact on small producers and organizations.
